DLH HOLDINGS CORP (DLHC) Fundamental Analysis & Valuation

NASDAQ:DLHC • US23335Q1004

Current stock price

5.98 USD
-0.04 (-0.66%)
Last:

This DLHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. DLHC Profitability Analysis

1.1 Basic Checks

  • In the past year DLHC has reported negative net income.
  • DLHC had a positive operating cash flow in the past year.
  • DLHC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years DLHC had a positive operating cash flow.
DLHC Yearly Net Income VS EBIT VS OCF VS FCFDLHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

1.2 Ratios

  • DLHC has a Return On Assets (-0.38%) which is in line with its industry peers.
  • DLHC has a Return On Equity (-0.96%) which is in line with its industry peers.
  • DLHC's Return On Invested Capital of 4.49% is in line compared to the rest of the industry. DLHC outperforms 48.24% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DLHC is below the industry average of 12.37%.
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROIC 4.49%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
DLHC Yearly ROA, ROE, ROICDLHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • In the last couple of years the Profit Margin of DLHC has declined.
  • DLHC's Operating Margin of 3.90% is in line compared to the rest of the industry. DLHC outperforms 47.06% of its industry peers.
  • In the last couple of years the Operating Margin of DLHC has declined.
  • DLHC has a Gross Margin of 18.68%. This is in the lower half of the industry: DLHC underperforms 75.29% of its industry peers.
  • DLHC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.9%
PM (TTM) N/A
GM 18.68%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
DLHC Yearly Profit, Operating, Gross MarginsDLHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DLHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLHC is destroying value.
  • The number of shares outstanding for DLHC has been increased compared to 1 year ago.
  • DLHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DLHC has an improved debt to assets ratio.
DLHC Yearly Shares OutstandingDLHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
DLHC Yearly Total Debt VS Total AssetsDLHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • DLHC has an Altman-Z score of 1.63. This is a bad value and indicates that DLHC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of DLHC (1.63) is comparable to the rest of the industry.
  • DLHC has a debt to FCF ratio of 4.41. This is a neutral value as DLHC would need 4.41 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.41, DLHC is in line with its industry, outperforming 49.41% of the companies in the same industry.
  • DLHC has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of DLHC (1.03) is worse than 75.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Altman-Z 1.63
ROIC/WACC0.45
WACC9.99%
DLHC Yearly LT Debt VS Equity VS FCFDLHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • DLHC has a Current Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of DLHC (0.97) is worse than 78.82% of its industry peers.
  • DLHC has a Quick Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DLHC (0.97) is worse than 78.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
DLHC Yearly Current Assets VS Current LiabilitesDLHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DLHC Growth Analysis

3.1 Past

  • DLHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.55%.
  • Measured over the past years, DLHC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.88% on average per year.
  • DLHC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.04%.
  • The Revenue has been growing by 10.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%

3.2 Future

  • DLHC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -120.36% yearly.
  • Based on estimates for the next years, DLHC will show a very negative growth in Revenue. The Revenue will decrease by -17.69% on average per year.
EPS Next Y-569.2%
EPS Next 2Y-120.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.28%
Revenue Next 2Y-17.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DLHC Yearly Revenue VS EstimatesDLHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
DLHC Yearly EPS VS EstimatesDLHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. DLHC Valuation Analysis

4.1 Price/Earnings Ratio

  • DLHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLHC Price Earnings VS Forward Price EarningsDLHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • 84.71% of the companies in the same industry are more expensive than DLHC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DLHC indicates a rather cheap valuation: DLHC is cheaper than 97.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.86
EV/EBITDA 7.41
DLHC Per share dataDLHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as DLHC's earnings are expected to decrease with -120.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-120.36%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DLHC Dividend Analysis

5.1 Amount

  • DLHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DLHC Fundamentals: All Metrics, Ratios and Statistics

DLH HOLDINGS CORP

NASDAQ:DLHC (4/27/2026, 11:27:43 AM)

5.98

-0.04 (-0.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-09
Earnings (Next)05-06
Inst Owners67.68%
Inst Owner Change1.93%
Ins Owners12.42%
Ins Owner Change1.19%
Market Cap86.65M
Revenue(TTM)322.61M
Net Income(TTM)-1.08M
Analysts82.86
Price Target10.2 (70.57%)
Short Float %0.33%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-126.05%
Min EPS beat(2)-296.08%
Max EPS beat(2)43.98%
EPS beat(4)1
Avg EPS beat(4)-67.51%
Min EPS beat(4)-296.08%
Max EPS beat(4)43.98%
EPS beat(8)3
Avg EPS beat(8)-33.61%
EPS beat(12)6
Avg EPS beat(12)-22.6%
EPS beat(16)9
Avg EPS beat(16)-9.67%
Revenue beat(2)0
Avg Revenue beat(2)-4.53%
Min Revenue beat(2)-5.28%
Max Revenue beat(2)-3.79%
Revenue beat(4)0
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-4.03%
Revenue beat(12)1
Avg Revenue beat(12)-4.06%
Revenue beat(16)2
Avg Revenue beat(16)-3.11%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-31.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF 2.86
P/OCF 2.89
P/B 0.77
P/tB N/A
EV/EBITDA 7.41
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)2.09
FCFY34.92%
OCF(TTM)2.07
OCFY34.6%
SpS22.26
BVpS7.74
TBVpS-7.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROCE 5.19%
ROIC 4.49%
ROICexc 4.5%
ROICexgc 66.78%
OM 3.9%
PM (TTM) N/A
GM 18.68%
FCFM 9.38%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
ROICexc(3y)7.49%
ROICexc(5y)11.97%
ROICexgc(3y)141.56%
ROICexgc(5y)N/A
ROCE(3y)8.65%
ROCE(5y)13.18%
ROICexgc growth 3Y-13.01%
ROICexgc growth 5Y-1.07%
ROICexc growth 3Y-36.15%
ROICexc growth 5Y-8.79%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Debt/EBITDA 3.9
Cap/Depr 1.58%
Cap/Sales 0.08%
Interest Coverage 0.97
Cash Conversion 100.76%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.63
F-Score4
WACC9.99%
ROIC/WACC0.45
Cap/Depr(3y)3.44%
Cap/Depr(5y)4.59%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.14%
Profit Quality(3y)1375.61%
Profit Quality(5y)915.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
EPS Next Y-569.2%
EPS Next 2Y-120.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%
Revenue Next Year-32.28%
Revenue Next 2Y-17.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.94%
EBIT growth 3Y-20.88%
EBIT growth 5Y3.11%
EBIT Next Year17.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.16%
FCF growth 3Y295.63%
FCF growth 5Y3.55%
OCF growth 1Y6.59%
OCF growth 3Y165.32%
OCF growth 5Y3.6%

DLH HOLDINGS CORP / DLHC Fundamental Analysis FAQ

What is the fundamental rating for DLHC stock?

ChartMill assigns a fundamental rating of 2 / 10 to DLHC.


What is the valuation status for DLHC stock?

ChartMill assigns a valuation rating of 2 / 10 to DLH HOLDINGS CORP (DLHC). This can be considered as Overvalued.


Can you provide the profitability details for DLH HOLDINGS CORP?

DLH HOLDINGS CORP (DLHC) has a profitability rating of 3 / 10.


What is the expected EPS growth for DLH HOLDINGS CORP (DLHC) stock?

The Earnings per Share (EPS) of DLH HOLDINGS CORP (DLHC) is expected to decline by -569.2% in the next year.